The scientific team of IMAVITA is composed of the following people (in order of appearance):


Eric LACOSTE
CEO / CSO, Founder, DVM, DU Pharmacokinetics

Eric is a veterinarian from the National Veterinary School of Toulouse (ENVT) with a degree in pharmacokinetics / pharmcodynamics (DU: University Diploma). After his thesis (Molecular mechanisms of DNA virus-induced oncogenesis), he spent 2 years as Project manager at Hoechst Roussel Vet in Fortaleza, Brazil. From 1999 to 2008, he worked at Avogadro, France as Project Manager and during the last 4 years as Director of the Biochemistry/Biomarkers Laboratory. From 2009 to 2012, he was at the origin, founder and Chief Scientific Officer of Synelvia.
Eric brings his experience of laboratory, animal facilities management and his knowledge in biomarkers development and validation, PK/PD relationships, pre-clinical pathology models and pre-clinical imaging.


Bernard JACQUIN
CFO, Founder

Bernard has an important career in financing of major and small companies in Americas. He brings his knowledge as senior in financing, accountability and strategical development.


Virginie ALBINET
PhD, Physiopathologist, Project Leader

Virginie is PhD graduated on 2012. She has spent 4 years at the laboratory of the Center of Oncology Research of Toulouse (Centre de Recherche en Cancérologie de Toulouse (CRCT) U1037 INSERM / UPS / CNRS) and has worked on the role of sphingosine 1-phosphate in melanoma-stroma interactions.


Jeanne CHAPEL
MSc, Research Scientist
Jeanne is graduated from University of Paul Sabatier, Toulouse, France (Master Bioingéniérie 2015). Jeanne works in the in vitro lab and helps in applications of in vivo models for drug efficacy evaluation.


Elisabeth BONNARD
PhD, Neuropharmacologist, Project Leader
Elisabeth was graduated on 2004 at the l’Institut de Pharmacologie et de Biologie Structurale, CNRS, Toulouse. She has 10 years of experience as head of pharmacology et PharmaLeads, Paris, France. She brings experience in preclinical development, in vivo models in neurology. Elisabeth actually helps in the implementation of new preclinical models in the areas of neurology and dermatology.


Claire ANTOINE
MSc, Research Scientist
Claire is graduated from University of Paul Sabatier, Toulouse, France (Master Toxicologie 2017). Claire works in the in vitro lab and helps in applications of in vivo models for drug efficacy evaluation.


Maud CHUSSEAU
MSc, Research Scientist
Maud is graduated from University of Claude Bernard, Lyon, France (Master Pharmacology / Animal experimentation 2007). Maud works in the in vitro lab and in vivo models for drug efficacy evaluation and has experience in qPCR, animals surgery and small animal imaging.


Julia ROCHOTTE
PhD, Immunologist, Project Leader

Julia is a young PhD graduated on 2014. She has spent 7 years at the laboratory of the Center of Oncology Research of Toulouse (Centre de Recherche en Cancérologie de Toulouse (CRCT) U1037 INSERM / UPS / CNRS) with an important background in immunology and immuno-oncology.


The team is completed by external competences (consulting / collaborations) in various fields:

Imavita team / Preclinical CRO

Gravityscan Badge